Table 1 The baseline characteristics of participants.
Serum calcium (mg/dL) | T1 (< 8.5) N = 3086 | T2 (8.6–9.1) N = 3721 | T3 (> 9.2) N = 3616 | P-value |
|---|---|---|---|---|
Age (year) | 66.25 ± 15.03 | 67.47 ± 14.74 | 67.36 ± 14.74 | 0.001 |
BMI (kg/m2) | 26.7 (33.07, 31.4) | 27.27 (23.30, 32.04) | 27.45 (23.66, 31.98) | 0.573 |
Sex | < 0.001 | |||
Male, n (%) | 1697 (55.01%) | 1988 (53.43%) | 1724 (47.68%) | |
Female, n (%) | 1388 (44.99%) | 1733 (46.57%) | 1892 (52.32%) | |
Ethnicity | < 0.001 | |||
African–American, n (%) | 307 (10.00%) | 433 (11.70%) | 579 (16.10%) | |
Asian, n (%) | 65 (2.12%) | 96 (2.59%) | 74 (2.06%) | |
Caucasian, n (%) | 2274 (74.07%) | 2750 (74.28%) | 2643 (73.48%) | |
Hispanic, n (%) | 219 (7.13%) | 179 (4.84%) | 115 (3.20%) | |
Native American, n (%) | 25 (0.81%) | 14 (0.38%) | 8 (0.22%) | |
Unknown, n (%) | 180 (5.86%) | 230 (6.21%) | 178 (4.95%) | |
AF, n (%) | 415 (13.45%) | 466 (12.52%) | 382 (10.56%) | 0.001 |
ACS, n (%) | 171 (5.54%) | 143 (3.84%) | 130 (3.60%) | < 0.001 |
CHF, n (%) | 202 (6.55%) | 169 (4.54%) | 145 (4.01%) | < 0.001 |
COPD, n (%) | 149 (4.83%) | 164 (4.41%) | 119 (3.29%) | 0.007 |
Diabetes, n (%) | 410 (13.75%) | 497 (13.36%) | 431 (12.23%) | 0.162 |
Hypertension, n (%) | 922 (29.88%) | 1239 (33.30%) | 1137 (31.44%) | < 0.001 |
Cancer, n (%) | 35 (1.13%) | 28 (0.75%) | 26 (0.72%) | 0.129 |
Type of stroke | 0.399 | |||
Hemorrhagic stroke, n (%) | 988 (47.52%) | 1163 (46.91%) | 1148 (47.11%) | |
Ischemic stroke, n (%) | 1075 (51.71%) | 1282 (51.71%) | 1258 (51.62%) | |
Others | 16 (0.77%) | 34 (1.37%) | 31 (1.27%) | |
Hb (g/L) | 11.64 ± 2.37 | 12.88 ± 2.14 | 13.55 ± 2.06 | < 0.001 |
PC (× 109/L) | 212.84 ± 88.35 | 226.09 ± 82.75 | 239.43 ± 90.05 | < 0.001 |
BUN (mmol/L) | 5.67 ± 3.04 | 5.34 ± 2.70 | 6.05 ± 3.08 | 0.254 |
Scr (mg/dL) | 1.41 ± 1.52 | 1.18 ± 1.13 | 1.25 ± 1.21 | < 0.001 |
Ionized calcium (mg/dL) | 3.40 ± 1.63 | 3.88 ± 1.51 | 4.07 ± 1.50 | < 0.001 |
Serum calcium (mg/dL) | 7.95 ± 0.76 | 8.86 ± 0.17 | 9.60 ± 0.45 | < 0.001 |
ACSC (mg/dL) | 8.71 ± 0.73 | 9.62 ± 0.16 | 10.36 ± 0.48 | < 0.001 |
Mg (mmol/L) | 1.88 ± 0.39 | 1.91 ± 0.31 | 1.92 ± 0.34 | < 0.001 |
GCS, median (Q1, Q3) | 14.00 (10.00–15.00) | 15.00 (11.25–15.00) | 14.00 (11.00–15.00) | 0.3275 |
Cardiac arrest | 106 (3.43%) | 44 (1.18%) | 51 (1.41%) | < 0.001 |
Hospital mortality | 547 (17.94%) | 468 (12.75%) | 415 (11.63%) | < 0.001 |
Hospital stay (day) | 6.22 (3.26–12.16) | 5.10 (2.92–9.59) | 4.79 (2.75–8.57) | < 0.001 |
ICU mortality | 321 (10.40%) | 249 (6.69%) | 229 (6.33%) | < 0.001 |
ICU stay (day) | 2.38 (1.22–5.58) | 1.96 (1.10–3.90) | 1.90 (1.07–3.65) | < 0.001 |